NVDA+0.84%AAPL−2.51%GOOGL−1.17%MSFT−2.04%AMZN−0.15%TSM+2.85%SPCX−1.20%AVGO+0.21%
StockVS

NASDAQ · Health · USD · ETF

iShares Biotechnology ETF (IBB) ETF Analysis

IBB
Expense ratio 0.44% Yield 0.2% Assets $10.47B Since February 5, 2001 Family iShares
$211.92
−$1.89 (−0.88%)

September 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare IBB with… →

Recent News

News provided by third-party sources. Not financial advice.

Top Holdings

# Symbol Name Weight
1 GILD Gilead Sciences Inc 9.12%
2 VRTX Vertex Pharmaceuticals Inc 8.77%
3 AMGN Amgen Inc 8%
4 REGN Regeneron Pharmaceuticals Inc 6.48%
5 ALNY Alnylam Pharmaceuticals Inc 3.79%
6 ARGX argenx SE ADR 2.94%
7 INSM Insmed Inc 2.85%
8 NTRA Natera Inc 2.62%
9 BIIB Biogen Inc 2.28%
10 ONC BeOne Medicines Ltd ADR 2.13%

Analysis

Data-derived

Fund Overview

iShares Biotechnology ETF (IBB) is an exchange-traded fund in the Health category. The fund is issued by iShares. It has been trading since February 5, 2001. Total net assets stand at $10.47B. Annual costs run at an expense ratio of 0.44%. On a $10,000 position that is $44.00 a year.

The largest positions on file are Gilead Sciences Inc (GILD), Vertex Pharmaceuticals Inc (VRTX), and Amgen Inc (AMGN). Gilead Sciences Inc alone accounts for 9.12% of the portfolio. The ten largest positions together make up 48.98% of the fund.

Performance Analysis

The most recent close on file for IBB is $211.92, dated September 4, 2026. Over the trailing twelve months the price has returned +51.25%. The stored price history starts on February 7, 2025, and the total return since then is +54.33%. The trailing distribution yield is 0.2%. The provider also reports a 3 years average return of +18.37%.

2026 is still running; the price is +25.57% year to date.

Price & Risk Profile

The 52-week range on file runs from $138.79 to $217.12. The latest close sits 52.69% above that 52-week low. Annualized volatility over the trailing 1 year is 21.94%. Beta against the wider market is reported at 0.74. The volatility figure is calculated from the stored daily closes, the same series the charts on this page use.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Health ETFs

XLV

State Street Health Care Select Sector SPDR ETF

$43.91B

 VHT

Vanguard Health Care Index Fund ETF Shares

$21.93B

 XBI

State Street SPDR S&P Biotech ETF

$11.40B

 ARKG

ARK Genomic Revolution ETF

$2.02B
View all Health ETFs →